Return On Equity
-36%
Trailing 12 months · Through 31 Dec 2025
Prior-year balance unavailable; uses current balance.
Period Q4 2025 · Filed 06 Feb 2026
Return On Equity
-36%
Trailing 12 months · Through 31 Dec 2025
Prior-year balance unavailable; uses current balance.
Return On Assets
1.6%
Trailing 12 months · Through 31 Dec 2025
Prior-year balance unavailable; uses current balance.
Current Ratio
0.27x
Period-end balance · Through 31 Dec 2025
Debt-to-equity
-1.12x
Period-end balance · Through 31 Dec 2025
| Metric | Latest value | YoY relative change |
|---|---|---|
| Return On Equity |
-36%
Trailing 12 months · 31 Dec 2025
Prior-year balance unavailable; uses current balance.
|
|
| Return On Assets |
1.6%
Trailing 12 months · 31 Dec 2025
Prior-year balance unavailable; uses current balance.
|
| Metric | Latest value | YoY relative change |
|---|---|---|
| Current Ratio |
0.27x
Period-end balance · 31 Dec 2025
|
|
| Debt-to-equity |
-1.12x
Period-end balance · 31 Dec 2025
|
| Metric | Latest value | YoY relative change |
|---|---|---|
| Net Income (Loss) Attributable to Parent |
$3,584,813
Trailing 12 months · 31 Dec 2025
|
These supporting metrics stay fully source-backed for deeper research. Scan the latest value and reported period first, then open a metric page when you need the full filing trail.
| Metric | Latest value | YoY relative change |
|---|---|---|
| Accrued Liabilities, Current |
$739,510
Period-end balance · 31 Dec 2025
|
|
| Assets |
$226,537,549
Period-end balance · 31 Dec 2025
|
|
| Assets, Current |
$404,372
Period-end balance · 31 Dec 2025
|
|
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
$267,719
Period-end balance · 31 Dec 2025
|
|
| General and Administrative Expense |
$2,511,945
Trailing 12 months · 31 Dec 2025
|
|
| Liabilities |
$10,314,510
Period-end balance · 31 Dec 2025
|
|
| Liabilities and Equity |
$226,537,549
Period-end balance · 31 Dec 2025
|
|
| Liabilities, Current |
$1,514,510
Period-end balance · 31 Dec 2025
|
|
| Preferred Stock, Par or Stated Value Per Share |
0.0001
Period-end balance · 31 Dec 2025
|
|
| Preferred Stock, Shares Authorized |
5,000,000
Period-end balance · 31 Dec 2025
|
|
| Retained Earnings (Accumulated Deficit) |
-$9,874,516
Period-end balance · 31 Dec 2025
|
|
| Stockholders' Equity Attributable to Parent |
-$9,873,719
Period-end balance · 31 Dec 2025
|
Based on company facts extracted from SEC 10-Q/10-K XBRL filings where available. Open metric pages to inspect the reported history.
Company facts change as new 10-Q and 10-K filings update the latest reported period, headline values, and cross-company comparison context.
Freshness comes from the latest SEC company facts period available for this filer and the linked metric history pages.
Latest update
Latest financial period: Q4 2025. Reopen this facts page to verify the newest reported period against the prior baseline.
Update date
06 Feb 2026
Page type
Company facts
Latest period
Q4 2025
SEC-backed company facts were refreshed from filings filed on 06 Feb 2026.
Benchmark Context
Return On Equity does not yet have enough prior-period data for a historical comparison on this page.
Compared with
Compared with XANADU QUANTUM TECHNOLOGIES FORMER SPAC INC.'s recent history first. Same-industry peer context appears only when enough SEC-backed benchmark coverage exists.
Why this is notable
Return On Equity already has a self-history signal here, but same-industry benchmark context waits until the benchmark sample is strong enough.
Industry benchmark context uses SEC-reported values from the same methodology version. Latest periods may differ across companies.
Based on company facts extracted from SEC 10-Q/10-K XBRL filings where available. Open company facts to inspect the reported metric history.
Latest financial snapshot (2025-12-31) highlights Return On Equity -36.3%, Return On Assets 1.6%, and Current Ratio 0.27x.
SEC-only DCF estimate using a normalized free cash flow base, cash, debt, and reported share count when available.
USD inputs only. Cash and complete debt must share the latest balance date. Missing balances are unknown, never zero; equity value and market EV remain unavailable until both are verified.
Equity value = DCF enterprise value + cash − debt. Cash flow uses matching annual or trailing-12-month periods.
Transparent 0-100 scoring model based on profitability, financial health, and growth factors.
6.8/100
Weak Confidence low
-36%
Metric score 0.0/100
1.6%
Metric score 0.0/100
No strong signals yet.
Return On Equity, Return On Assets, and Current Ratio
This score is transparent and deterministic. We weight profitability, financial health, and growth metrics, then renormalize weights when SEC data is missing.
| Metric | Weight | V1 threshold |
|---|---|---|
| ROIC | 20 | 5% to 20% |
| ROE | 15 | 8% to 25% |
| ROA | 10 | 2% to 10% |
| Operating Margin | 5 | 5% to 25% |
| Current Ratio | 12 | 1.0x to 2.0x |
| Quick Ratio | 8 | 0.8x to 1.5x |
| Debt to Equity | 10 | 0.3x to 2.0x (lower is better) |
| Revenue YoY | 10 | -10% to +20% |
| Net Income YoY | 10 | -10% to +20% |
Metrics are computed with a market-consensus convention designed for cross-portal comparability.
CIK / security context first